Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 09 Nov 2023 for EQRx, Inc., €1.3M.
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Melanie Nallicheri: trading record in brief
Melanie Nallicheri (chief executive) discloses dealings in 2 companies, chiefly Foundation Medicine, Inc. and EQRx, Inc. In total, 12 filings cover trades dated from 2 October 2017 to 9 November 2023.
On the market, this insider has only sold: 4 sales, €572k in total. The rest of the record consists of 3 share grants and 1 option exercise.
Most recently, on 9 November 2023, the filings show a transaction in EQRx, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Melanie Nallicheri
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
626,999 shares@ US$2.21100.0% of flowCommon StockSEC:0000899243-23-020309:0
5,679,247 sharesCommon StockSEC:0000899243-21-049127:0
2 of 2 declarations
